Table 3.
Characteristic | Subgroup LDL < 70 mg/dl (n = 223) | |||||||
---|---|---|---|---|---|---|---|---|
Univariate logistic regressions | Multivariate logistic regression analysis with backward selection | |||||||
hsCRP < 2 mg/l (n = 154) (%) | hsCRP ≥ 2 mg/l (n = 69) (%) | Odds ratio | p value | Odds ratio | p value | 95% CI | ||
Female sex | 18 | 16 | 0.85 | 0.658 | ||||
Age > 75 yrs | 39 | 46 | 1.35 | 0.287 | ||||
Lipoprotein (a) > 30 mg/dl | 24 | 32 | 1.52 | 0.180 | ||||
LDL-cholesterol > 70 mg/dl | 0 | 0 | 1.00 | |||||
HbA1c > 6.5% | 22 | 23 | 1.01 | 0.969 | ||||
proBNP > 500 pg/ml | 35 | 63 | 3.15 | 0.004 | 3.49 | 0.007 | 1.41 | 8.60 |
Hypertension | 79 | 89 | 2.31 | 0.046 | ||||
Diabetes | 30 | 34 | 1.21 | 0.515 | ||||
Smoking | 43 | 46 | 1.13 | 0.664 | ||||
BMI > 30 kg/m2 | 13 | 25 | 2.22 | 0.028 | ||||
Stable CHD with revascularization procedure | 43 | 39 | 0.88 | 0.659 | ||||
History of acute coronary syndrome | 50 | 45 | 0.83 | 0.506 | ||||
No statin | 2 | 8 | 3.32 | 0.070 | ||||
Statin low dose | 19 | 36 | 2.37 | 0.006 | ||||
Statin high dose | 79 | 56 | 0.35 | 0.001 | 0.29 | 0.007 | 0.11 | 0.72 |
Ezetimibe | 42 | 16 | 0.26 | < 0.001 | 0.35 | 0.042 | 0.13 | 0.96 |
PSCK9-inhibitor | 0 | 1 | 1.00 | |||||
Metabolic syndrome | 24 | 30 | 1.35 | 0.338 |
yrs years, BMI body mass index, CHD coronary heart disease